Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Vaccine

• Publication date

  2017-10-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2017.09.050PMID 28951086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

  2019cited by this paper
• Prevalence of and outcomes from Staphylococcus aureus pneumonia among hospitalized patients in the United States, 2009‐2012

  2017cited by this paper
• Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.

  2015influential reference
• Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

  2015cited by this paper
• [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination].

  2014cited by this paper
• Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France

  2014influential reference
• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2014cited by this paper
• Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.

  2014cited by this paper
• Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis.

  2014cited by this paper
• Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

  2013influential reference
• U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

  2013cited by this paper
• Bacterial meningitis in the United States, 1998-2007.

  2011cited by this paper
• NEUROLOGIC MANIFESTATIONS OF PEDIATRIC NOVEL H1N1 INFLUENZA INFECTION

  2011cited by this paper
• Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2010cited by this paper
• Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children

  2010cited by this paper
• Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis

  2010influential reference
• Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998-2006).

  2009cited by this paper
• Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.

  2009cited by this paper
• Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

  2008cited by this paper
• Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.

  2008influential reference
• Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.

  2008cited by this paper
• Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

  2008cited by this paper
• Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

  2007cited by this paper
• Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

  2004cited by this paper
• Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2000cited by this paper
• Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Comorbidity measures for use with administrative data.

  1998influential reference

• Real-world utilization and potential clinical and economic value of recombinant zoster vaccine and select preventive services recommended for older adults in the United States.

  2025cites this paper
• Fulminant Multidrug-Resistant Streptococcus pneumoniae Meningoencephalitis After Elective ENT Surgery: A Case Report

  2025influential citation
• Genomic Surveillance Reveals Vaccine-Associated Shifts in Pediatric Invasive Streptococcus pneumoniae in Tunisia

  2025cites this paper
• Advances in the pathogenesis and treatment of pneumococcal meningitis

  2024influential citation
• How common is otogenic meningitis? A retrospective study in southern Sweden over 18 years

  2024cites this paper
• Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US

  2021cites this paper
• Community-acquired bacterial meningitis.

  2021cites this paper
• Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland.

  2021cites this paper
• The Impact of Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease

  2020influential citation
• Resurgence of pneumococcal meningitis in Europe and Northern America.

  2020cites this paper
• Trends in Pediatric Primary Care Visits Among Commercially Insured US Children, 2008-2016.

  2020cites this paper
• Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era

  2020cites this paper
• Pathology Associated With Streptococcus spp. Infection in Baboons (Papio spp.)

  2020cites this paper
• Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine

  2020cites this paper
• Preventive vaccination of pneumococcal disease under the dissemination of COVID-19

  2020cites this paper
• Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines

  2020cites this paper
• Design and evaluation of single-dose polyanhydride nanovaccines against bacterial respiratory pathogens

  2019cites this paper
• Recurrent Pneumococcal Meningitis Secondary to Nasoethmoidal Meningocele

  2019cites this paper
• Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016

  2019cites this paper
• Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005–2018

  2019cites this paper
• Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey.

  2018cites this paper
• A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13

  2018cites this paper
• Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity

  2018cites this paper